Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cindy Delbrook"'
Autor:
David F. Stroncek, Pamela L. Wolters, Terry J. Fry, Maryalice Stetler-Stevenson, Haneen Shalabi, Cindy Delbrook, Crystal L. Mackall, Staci Martin, Nirali N. Shah, Daniel W. Lee, Eva H. Baker, Seth M. Steinberg, Bonnie Yates, Constance M. Yuan
Publikováno v:
J Clin Oncol
PURPOSE CD19 chimeric antigen receptor (CD19-CAR) T cells induce high response rates in children and young adults (CAYAs) with B-cell acute lymphoblastic leukemia (B-ALL), but relapse rates are high. The role for allogeneic hematopoietic stem-cell tr
Autor:
Staci Martin, Maryalice Stetler-Stevenson, Sandhya R. Panch, Seth M. Steinberg, Steven L. Highfill, Haris Qureshi, Cindy Delbrook, Haiying Qin, Alina Dulau-Florea, Hao-Wei Wang, Crystal L. Mackall, Jianjian Jin, Constance M. Yuan, Lauren Little, Pamela L. Wolters, David F. Stroncek, Haneen Shalabi, Leah Hoffman, Dalia Salem, Terry J. Fry, Nirali N. Shah, Anusha Ponduri, Minh Tran, Bonnie Yates, Amanda K. Ombrello
Publikováno v:
J Clin Oncol
PURPOSE Patients with B-cell acute lymphoblastic leukemia who experience relapse after or are resistant to CD19-targeted immunotherapies have limited treatment options. Targeting CD22, an alternative B-cell antigen, represents an alternate strategy.
Autor:
Brandon M. Wiley, Amita Kulshreshtha, Bonnie Yates, Daniel W. Lee, Stanislav Sidenko, Haneen Shalabi, Julia W. Cohen, Nirali N. Shah, Cindy Delbrook, Crystal L. Mackall, Vandana Sachdev, Doug R Rosing
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
BackgroundChimeric antigen receptor (CAR) T-cell-associated cytokine release syndrome (CRS) may present with tachycardia, hemodynamic instability and reduced cardiac function. Pediatric CAR studies examining cardiac toxicity are limited.MethodsWe rep
Autor:
Nirali N. Shah, Mark J. Roth, Haneen Shalabi, Amita Kulshreshtha, Constance M. Yuan, Dalia A. Salem, Crystal L. Mackall, Alina Dulau-Florea, Terry J. Fry, Maryalice Stetler-Stevenson, Armando C. Filie, Alan S. Wayne, Daniel W. Lee, Joanne Derdak, Bonnie Yates, Gaurav K. Gupta, Cindy Delbrook
Publikováno v:
Pediatr Blood Cancer
Background Accurate disease detection is integral to risk stratification in B-cell acute lymphoblastic leukemia (ALL). The gold standard used to evaluate response in the United States includes morphologic evaluation and minimal residual disease (MRD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c89c2d44636318636e59063161f9bd
https://europepmc.org/articles/PMC7036332/
https://europepmc.org/articles/PMC7036332/